ZVRA
Zevra Therapeutics Inc.
11.30$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 23 | Q3 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 8.0% | 5.0% | 95.3% | 80.3% | 62.3% | 11.3% | 6.6% | 47.8% | 6.0% | 4.5% | 6.3% | 3.8% | 5.0% | |
| 92.0% | 95.0% | 4.7% | 19.7% | 37.7% | 88.7% | 93.4% | 52.2% | 94.0% | 95.5% | 93.7% | 96.2% | 95.0% | |
| 87.8% | 424.8% | 312.8% | 236.5% | 296.2% | 82.3% | 16.0% | 13.3% | 13.2% | 7.7% | 12.1% | 11.3% | 11.0% | |
| 82.7% | 201.0% | 290.0% | 36.1% | 438.6% | 13.3% | 95.8% | 80.3% | 65.0% | 59.6% | 57.4% | 41.7% | 54.8% | |
| 165.8% | 625.7% | 602.8% | 554.5% | 776.7% | 216.7% | 119.7% | 326.7% | 78.1% | 68.2% | 69.5% | 53.9% | 66.3% | |
| -73.8% | -530.7% | -598.1% | -534.8% | -739.0% | -128.0% | -26.3% | -274.5% | 15.9% | 27.3% | 24.4% | 42.3% | 28.7% | |
| 2.3% | 12.6% | 21.5% | 47.4% | 62.6% | 18.2% | 9.7% | 7.8% | 7.9% | 5.7% | 4.7% | 0.0% | 4.2% | |
| -31.3% | -352.0% | -487.4% | -446.3% | -899.2% | -169.1% | -9.4% | 297.2% | -3.7% | 37.1% | 123.7% | 32.3% | 50.9% | |
| -0.9% | 6.1% | -2.0% | 1.6% | – | 127.6% | 5.8% | 8.5% | -1.7% | 1.5% | 19.1% | 10.2% | 8.1% | |
| -30.4% | -358.1% | -485.3% | -447.9% | -899.2% | -296.8% | -15.2% | 288.7% | -2.1% | 35.6% | 104.6% | 22.1% | 42.8% | |
| -28.0% | -464.2% | -420.3% | -363.7% | -792.9% | -137.2% | 8.3% | 311.3% | 5.6% | 43.9% | 120.0% | 33.1% | 53.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.